Human bocavirus VP2 upregulates IFN-β pathway by inhibiting ring finger protein 125-mediated ubiquitination of retinoic acid-inducible gene-I

Journal of Immunology

Volumn 191, Issue 2, 2013, Pages 660-669

  Luo, Huanle ^a   Zhang, Zhenfeng ^a   Zheng, Zhenhua ^a   Ke, Xianliang ^a   Zhang, Xiaowei ^a   Li, Qian ^a   Liu, Yan ^a   Bai, Bingke ^b   Mao, Panyong ^b   Hu, Qinxue ^a   Wang, Hanzhong ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b BEIJING 302 HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LUCIFERASE; MESSENGER RNA; PROTEIN VP2; RETINOIC ACID INDUCIBLE PROTEIN I; RING FINGER PROTEIN; RING FINGER PROTEIN 125; SERINE; UNCLASSIFIED DRUG;

ARTICLE; BOCAVIRUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; IFNB GENE; IMMUNOREGULATION; INNATE IMMUNITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; SENDAI VIRUS; UBIQUITINATION; UPREGULATION; VIRUS CELL INTERACTION; VIRUS IMMUNITY;

CAPSID PROTEINS; CELL LINE; DEAD-BOX RNA HELICASES; HEK293 CELLS; HELA CELLS; HUMAN BOCAVIRUS; HUMANS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SENDAI VIRUS; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84880120792     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202933     Document Type: Article

References (68)

1. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801. (Pubitemid 43261452)
2. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20: 197-216. (Pubitemid 34293424)
3. Stetson, D. B., and R. Medzhitov. 2006. Type I interferons in host defense. Immunity 25: 373-381. (Pubitemid 44354218)
4. Zhong, B., Y.-Y. Wang, and H.-B. Shu. 2010. Regulation of virus-triggered type I interferon signaling by cellular and viral proteins. Front. Biol. 5: 12-31.
5. Honda, K., A. Takaoka, and T. Taniguchi. 2006. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25: 349-360. (Pubitemid 44354220)
6. Takeuchi, O., and S. Akira. 2008. MDA5/RIG-I and virus recognition. Curr. Opin. Immunol. 20: 17-22.
7. Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5: 730-737. (Pubitemid 39023305)
8. Yoneyama, M., and T. Fujita. 2008. Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity 29: 178-181.
9. Kang, D. C., R. V. Gopalkrishnan, Q. Wu, E. Jankowsky, A. M. Pyle, and P. B. Fisher. 2002. mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc. Natl. Acad. Sci. USA 99: 637-642. (Pubitemid 34106564)
10. Meylan, E., J. Curran, K. Hofmann, D. Moradpour, M. Binder, R. Bartenschlager, and J. Tschopp. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172. (Pubitemid 41509355)
11. Kawai, T., K. Takahashi, S. Sato, C. Coban, H. Kumar, H. Kato, K. J. Ishii, O. Takeuchi, and S. Akira. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6: 981-988. (Pubitemid 41486182)
12. Xu, L.-G., Y.-Y. Wang, K.-J. Han, L.-Y. Li, Z. Zhai, and H.-B. Shu. 2005. VISA is an adapter protein required for virus-triggered IFN-β signaling. Mol. Cell 19: 727-740. (Pubitemid 41316668)
13. Yoneyama, M., W. Suhara, Y. Fukuhara, M. Fukuda, E. Nishida, and T. Fujita. 1998. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17: 1087-1095. (Pubitemid 28077662)
14. Sato, M., N. Tanaka, N. Hata, E. Oda, and T. Taniguchi. 1998. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Lett. 425: 112-116. (Pubitemid 28149751)
15. Lin, R., C. Heylbroeck, P. M. Pitha, and J. Hiscott. 1998. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18: 2986-2996. (Pubitemid 28183468)
16. Gack, M. U., Y. C. Shin, C.-H. Joo, T. Urano, C. Liang, L. Sun, O. Takeuchi, S. Akira, Z. Chen, S. Inoue, and J. U. Jung. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446: 916-920. (Pubitemid 46633167)
17. Oshiumi, H., M. Matsumoto, S. Hatakeyama, and T. Seya. 2009. Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-β induction during the early phase of viral infection. J. Biol. Chem. 284: 807-817.
18. Arimoto, K. i., H. Takahashi, T. Hishiki, H. Konishi, T. Fujita, and K. Shimotohno. 2007. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc. Natl. Acad. Sci. USA 104: 7500-7505. (Pubitemid 47185935)
19. Zhao, H., C. C. Li, J. Pardo, P. C. Chu, C. X. Liao, J. Huang, J. G. Dong, X. Zhou, Q. Huang, B. Huang, et al. 2005. A novel E3 ubiquitin ligase TRAC-1 positively regulates T cell activation. J. Immunol. 174: 5288-5297. (Pubitemid 40593167)
20. Chu, P., J. Pardo, H. Zhao, C. C. Li, E. Pali, M. M. Shen, K. Qu, S. X. Yu, B. C. Huang, P. Yu, et al. 2003. Systematic identification of regulatory proteins critical for T-cell activation. J. Biol. 2: 21.
21. Giannini, A. L., Y. Gao, and M. J. Bijlmakers. 2008. T-cell regulator RNF125/ TRAC-1 belongs to a novel family of ubiquitin ligases with zinc fingers and a ubiquitin-binding domain. Biochem. J. 410: 101-111. (Pubitemid 351300329)
22. Randall, R. E., and S. Goodbourn. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89: 1-47.
23. Zhang, Z., Z. Zheng, H. Luo, J. Meng, H. Li, Q. Li, X. Zhang, X. Ke, B. Bai, P. Mao, et al. 2012. Human bocavirus NP1 inhibits IFN-b production by blocking association of IFN regulatory factor 3 with IFNB promoter. J. Immunol. 189: 1144-1153.
24. Allander, T., M. T. Tammi, M. Eriksson, A. Bjerkner, A. Tiveljung-Lindell, and B. Andersson. 2005. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc. Natl. Acad. Sci. USA 102: 12891-12896. (Pubitemid 41279460)
25. Ma, X., R. Endo, N. Ishiguro, T. Ebihara, H. Ishiko, T. Ariga, and H. Kikuta. 2006. Detection of human bocavirus in Japanese children with lower respiratory tract infections. J. Clin. Microbiol. 44: 1132-1134.
26. Sloots, T. P., P. McErlean, D. J. Speicher, K. E. Arden, M. D. Nissen, and I. M. Mackay. 2006. Evidence of human coronavirus HKU1 and human bocavirus in Australian children. J. Clin. Virol. 35: 99-102. (Pubitemid 43020961)
27. Fry, A. M., X. Lu, M. Chittaganpitch, T. Peret, J. Fischer, S. F. Dowell, L. J. Anderson, D. Erdman, and S. J. Olsen. 2007. Human bocavirus: a novel parvovirus epidemiologically associated with pneumonia requiring hospitalization in Thailand. J. Infect. Dis. 195: 1038-1045. (Pubitemid 46452110)
28. Arthur, J. L., G. D. Higgins, G. P. Davidson, R. C. Givney, and R. M. Ratcliff. 2009. A novel bocavirus associated with acute gastroenteritis in Australian children. PLoS Pathog. 5: e1000391.
29. Kesebir, D., M. Vazquez, C. Weibel, E. D. Shapiro, D. Ferguson, M. L. Landry, and J. S. Kahn. 2006. Human bocavirus infection in young children in the United States: molecular epidemiological profile and clinical characteristics of a newly emerging respiratory virus. J. Infect. Dis. 194: 1276-1282. (Pubitemid 44630973)
30. Manning, A., V. Russell, K. Eastick, G. H. Leadbetter, N. Hallam, K. Templeton, and P. Simmonds. 2006. Epidemiological profile and clinical associations of human bocavirus and other human parvoviruses. J. Infect. Dis. 194: 1283-1290. (Pubitemid 44630974)
31. Allander, T., T. Jartti, S. Gupta, H. G. M. Niesters, P. Lehtinen, R. Osterback, T. Vuorinen, M. Waris, A. Bjerkner, A. Tiveljung-Lindell, et al. 2007. Human bocavirus and acute wheezing in children. Clin. Infect. Dis. 44: 904-910. (Pubitemid 46452052)
32. Mitui, M. T., S. M. Tabib, T. Matsumoto, W. Khanam, S. Ahmed, D. Mori, N. Akhter, K. Yamada, L. Kabir, A. Nishizono, et al. 2012. Detection of human bocavirus in the cerebrospinal fluid of children with encephalitis. Clin. Infect. Dis. 54: 964-967.
33. Edner, N., P. Castillo-Rodas, L. Falk, K. Hedman, M. Söderlund- Venermo, and T. Allander. 2012. Life-threatening respiratory tract disease with human bocavirus-1 infection in a 4-year-old child. J. Clin. Microbiol. 50: 531-532.
34. Ursic, T., A. Steyer, S. Kopriva, G. Kalan, U. Krivec, and M. Petrovec. 2011. Human bocavirus as the cause of a life-threatening infection. J. Clin. Microbiol. 49: 1179-1181.
35. Lindner, J., and S. Modrow. 2008. Human bocavirus - a novel parvovirus to infect humans. Intervirology 51: 116-122. (Pubitemid 352009470)
36. Li, Z., Y. Jiang, P. Jiao, A. Wang, F. Zhao, G. Tian, X. Wang, K. Yu, Z. Bu, and H. Chen. 2006. The NS1 gene contributes to the virulence of H5N1 avian influenza viruses. J. Virol. 80: 11115-11123. (Pubitemid 44706552)
37. Chen, Z., Y. Sahashi, K. Matsuo, H. Asanuma, H. Takahashi, T. Iwasaki, Y. Suzuki, C. Aizawa, T. Kurata, and S. Tamura. 1998. Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza. Vaccine 16: 1544-1549. (Pubitemid 28366091)
38. Yoneyama, M., W. Suhara, Y. Fukuhara, M. Sato, K. Ozato, and T. Fujita. 1996. Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3). J. Biochem. 120: 160-169. (Pubitemid 26258263)
39. Ehrhardt, C., C. Kardinal, W. J. Wurzer, T. Wolff, C. von Eichel-Streiber, S. Pleschka, O. Planz, and S. Ludwig. 2004. Rac1 and PAK1 are upstream of IKK-epsilon and TBK-1 in the viral activation of interferon regulatory factor-3. FEBS Lett. 567: 230-238. (Pubitemid 38748397)
40. Chang, T.-H., C.-L. Liao, and Y.-L. Lin. 2006. Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-kappaB activation. Microbes Infect. 8: 157-171. (Pubitemid 43139304)
41. Zheng, Z., H. Li, Z. Zhang, J. Meng, D. Mao, B. Bai, B. Lu, P. Mao, Q. Hu, and H. Wang. 2011. Enterovirus 71 2C protein inhibits TNF-α-mediated activation of NF-κB by suppressing IκB kinase β phosphorylation. J. Immunol. 187: 2202-2212.
42. Gresser, I., M. Aguet, L. Morel-Maroger, D. Woodrow, F. Puvion-Dutilleul, J. C. Guillon, and C. Maury. 1981. Electrophoretically pure mouse interferon inhibits growth, induces liver and kidney lesions, and kills suckling mice. Am. J. Pathol. 102: 396-402. (Pubitemid 11143433)
43. Heylbroeck, C., S. Balachandran, M. J. Servant, C. DeLuca, G. N. Barber, R. Lin, and J. Hiscott. 2000. The IRF-3 transcription factor mediates Sendai virus-induced apoptosis. J. Virol. 74: 3781-3792. (Pubitemid 30180321)
44. Peters, K., S. Chattopadhyay, and G. C. Sen. 2008. IRF-3 activation by Sendai virus infection is required for cellular apoptosis and avoidance of persistence. J. Virol. 82: 3500-3508. (Pubitemid 351429925)
45. Capobianchi, M. R., D. Matteucci, A. Giovannetti, E. Soldaini, M. Bendinelli, J. G. Stanton, and F. Dianzani. 1991. Role of interferon in lethality and lymphoid atrophy induced by Coxsackievirus B3 infection in mice. Viral Immunol. 4: 103-110.
46. Gresser, I., M. G. Tovey, C. Maury, and I. Chouroulinkov. 1975. Lethality of interferon preparations for newborn mice. Nature 258: 76-78.
47. Yuan, W., and R. M. Krug. 2001. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J. 20: 362-371. (Pubitemid 32126972)
48. Kim, M. J., S. Y. Hwang, T. Imaizumi, and J. Y. Yoo. 2008. Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J. Virol. 82: 1474-1483.
49. Guo, Z., L. M. Chen, H. Zeng, J. A. Gomez, J. Plowden, T. Fujita, J. M. Katz, R. O. Donis, and S. Sambhara. 2007. NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am. J. Respir. Cell Mol. Biol. 36: 263-269. (Pubitemid 46365276)
50. Lin, R., J. Lacoste, P. Nakhaei, Q. Sun, L. Yang, S. Paz, P. Wilkinson, I. Julkunen, D. Vitour, E. Meurs, and J. Hiscott. 2006. Dissociation of a MAVS/ IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J. Virol. 80: 6072-6083. (Pubitemid 43849185)
51. Siu, K. L., K. H. Kok, M. H. J. Ng, V. K. M. Poon, K. Y. Yuen, B. J. Zheng, and D. Y. Jin. 2009. Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3. TANK.TBK1/IKKepsilon complex. J. Biol. Chem. 284: 16202-16209.
52. Didcock, L., D. F. Young, S. Goodbourn, and R. E. Randall. 1999. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J. Virol. 73: 9928-9933.
53. Carlos, T. S., R. Fearns, and R. E. Randall. 2005. Interferon-induced alterations in the pattern of parainfluenza virus 5 transcription and protein synthesis and the induction of virus inclusion bodies. J. Virol. 79: 14112-14121. (Pubitemid 41552709)
54. Chatziandreou, N., D. Young, J. Andrejeva, S. Goodbourn, and R. E. Randall. 2002. Differences in interferon sensitivity and biological properties of two related isolates of simian virus 5: a model for virus persistence. Virology 293: 234-242.
55. Xu, D., K. Brumm, and L. Zhang. 2006. The latent membrane protein 1 of Epstein-Barr virus (EBV) primes EBV latency cells for type I interferon production. J. Biol. Chem. 281: 9163-9169. (Pubitemid 43864630)
56. Poppers, J., M. Mulvey, C. Perez, D. Khoo, and I. Mohr. 2003. Identification of a lytic-cycle Epstein-Barr virus gene product that can regulate PKR activation. J. Virol. 77: 228-236. (Pubitemid 36004963)
57. Zhang, J., S. C. Das, C. Kotalik, A. K. Pattnaik, and L. Zhang. 2004. The latent membrane protein 1 of Epstein-Barr virus establishes an antiviral state via induction of interferon-stimulated genes. J. Biol. Chem. 279: 46335-46342. (Pubitemid 39491629)
58. Kapoor, A., M. Hornig, A. Asokan, B. Williams, J. A. Henriquez, and W. I. Lipkin. 2011. Bocavirus episome in infected human tissue contains non-identical termini. PLoS One 6: e21362.
59. Huang, Q., X. Deng, Z. Yan, F. Cheng, Y. Luo, W. Shen, D. C. Lei-Butters, A. Y. Chen, Y. Li, L. Tang, et al. 2012. Establishment of a reverse genetics system for studying human bocavirus in human airway epithelia. PLoS Pathog. 8: e1002899.
60. Zhang, L., and J. S. Pagano. 2001. Interferon regulatory factor 7: a key cellular mediator of LMP-1 in EBV latency and transformation. Semin. Cancer Biol. 11: 445-453. (Pubitemid 33105023)
61. Zhang, L., and J. S. Pagano. 1997. IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency. Mol. Cell. Biol. 17: 5748- 5757.
62. Lin, R., P. Génin, Y. Mamane, and J. Hiscott. 2000. Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol. Cell. Biol. 20: 6342-6353. (Pubitemid 30650221)
63. Sukhu, L., O. Fasina, L. Burger, A. Rai, J. Qiu, and D. J. Pintel. 2013. Characterization of the nonstructural proteins of the bocavirus minute virus of canines. J. Virol. 87: 1098-1104.
64. Welcker, M., and B. E. Clurman. 2005. The SV40 large T antigen contains a decoy phosphodegron that mediates its interactions with Fbw7/hCdc4. J. Biol. Chem. 280: 7654-7658. (Pubitemid 40349658)
65. Zhang, B., A. Srirangam, D. A. Potter, and A. Roman. 2005. HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes. Oncogene 24: 2585-2588. (Pubitemid 40593050)
66. Le Goffic, R., J. Pothlichet, D. Vitour, T. Fujita, E. Meurs, M. Chignard, and M. Si-Tahar. 2007. Cutting edge: influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J. Immunol. 178: 3368-3372. (Pubitemid 46417600)
67. Minamitani, T., D. Iwakiri, and K. Takada. 2011. Adenovirus virus-associated RNAs induce type I interferon expression through a RIG-I-mediated pathway. J. Virol. 85: 4035-4040.
68. Slater, L., N. W. Bartlett, J. J. Haas, J. Zhu, S. D. Message, R. P. Walton, A. Sykes, S. Dahdaleh, D. L. Clarke, M. G. Belvisi, et al. 2010. Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog. 6: e1001178.